These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39006382)

  • 1. Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need.
    Borriello R; Esposto G; Mignini I; Gasbarrini A; Zocco MA
    World J Gastroenterol; 2024 Jul; 30(25):3143-3146. PubMed ID: 39006382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease.
    Chisthi MM
    World J Gastroenterol; 2024 May; 30(20):2629-2632. PubMed ID: 38855158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease.
    Zeng MH; Shi QY; Xu L; Mi YQ
    World J Gastroenterol; 2024 Mar; 30(10):1393-1404. PubMed ID: 38596499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.
    Ezzat WM
    World J Gastroenterol; 2024 May; 30(20):2633-2637. PubMed ID: 38855152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease.
    Liu CQ; Hu B
    World J Gastroenterol; 2024 Jul; 30(25):3179-3181. PubMed ID: 39006387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of non-alcoholic fatty liver disease: Lifestyle changes.
    Lv H; Liu Y
    World J Gastroenterol; 2024 Jun; 30(22):2829-2833. PubMed ID: 38947294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
    Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
    World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.
    Buzzetti E; Linden A; Best LM; Madden AM; Roberts D; Chase TJG; Freeman SC; Cooper NJ; Sutton AJ; Fritche D; Milne EJ; Wright K; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013156. PubMed ID: 34114650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
    Mazzotti A; Caletti MT; Brodosi L; Di Domizio S; Forchielli ML; Petta S; Bugianesi E; Bianchi G; Marchesini G
    J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.
    Kwak MS; Kim D
    Korean J Intern Med; 2018 Jan; 33(1):64-74. PubMed ID: 29202557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
    Ratziu V; Ghabril M; Romero-Gomez M; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):28-38. PubMed ID: 30300289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Wattacheril JJ; Abdelmalek MF; Lim JK; Sanyal AJ
    Gastroenterology; 2023 Oct; 165(4):1080-1088. PubMed ID: 37542503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern approach to the clinical management of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Loffredo L; Angelico F
    World J Gastroenterol; 2014 Jul; 20(26):8341-50. PubMed ID: 25024593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease Management: Dietary and Lifestyle Modifications.
    Nguyen V; George J
    Semin Liver Dis; 2015 Aug; 35(3):318-37. PubMed ID: 26378647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease - how to effectively fight the nowadays most common liver disease?
    Šmíd V
    Cas Lek Cesk; 2021; 160(2-3):65-70. PubMed ID: 34134495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of diet and lifestyle changes in nonalcoholic fatty liver disease.
    Nseir W; Hellou E; Assy N
    World J Gastroenterol; 2014 Jul; 20(28):9338-44. PubMed ID: 25071328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of NAFLD with diet, physical activity and exercise.
    Romero-Gómez M; Zelber-Sagi S; Trenell M
    J Hepatol; 2017 Oct; 67(4):829-846. PubMed ID: 28545937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.